The 2022 WHO classification reflects increases in the knowledge of the underlying
pathogenesis of parathyroid disease. In addition to the classic characteristic features of …

Opinion statement Parathyroid carcinoma is one of the rarest known malignancies that may
occur sporadically or as a part of a genetic syndrome. It accounts for approximately 1% of …

Atypical parathyroid adenomas represent a group of intermediate form of parathyroid
neoplasms of uncertain malignant potential which show some atypical histological features …

Parathyroid carcinoma is a rare endocrine malignancy. The reported incidence is from 0.5 to
5% of primary hyperparathyroidism cases in various series. The cause is unknown, but …

Introduction Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing
severe primary hyperparathyroidism (PHPT). PC is mainly a sporadic disease, but it may …

Background: Parathyroid carcinoma (PC) is rare and diagnostically challenging. Reported
outcomes are rather poor and the incidence might be increasing. Material and methods: We …

Recent data suggest an increase in the overall incidence of parathyroid disorders, with
primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is …

Pathologists are usually readily able to diagnose parathyroid tissues and diseases,
particularly when they have knowledge of the clinical information, laboratory findings, and …

Background Parathyroid carcinoma is a rare neoplasm that may present sporadically or in
the context of a genetic syndrome. Diagnosis and management are challenging due to the …

Parathyroid cancer is an uncommon malignancy and rare cause of primary
hyperparathyroidism (HPT) with a high morbidity and patient death in advanced cases …